Table 3.
Antibiotics |
|
Resistant | Intermediate | Sensitive | |||||
|
Range (µg/mL) | n (%) | Breakpoint (µg/mL) | n (%) | Breakpoint (µg/mL) | n (%) | Breakpoint (µg/mL) | ||
Azithromycin (n=188) | <0.016-16 | 2 (1.1)a | ≥8 | 2 (1.1)b | — | 184 (97.9) | ≤2 | ||
Cefixime (n=185) | <0.016-0.16 | 0 (0) | — | — | — | 185 (100) | ≤0.25c | ||
Ceftriaxone (n=188) | 0.002-1.5 | 2 (1.1)d | — | — | — | 186 (98.9) | ≤0.25c | ||
Ciprofloxacin (n=192) | 0.002-32 | 188 (97.9) | ≥1 | — | — | 4 (2.1)e | ≤0.061 | ||
Gentamicin (n=189) | 0.38-48 | 1 (0.5)f | ≥32 | 3 (1.6)g | 8-16 | 185 (97.9) | ≤4 |
aMinimum inhibition concentrations (MIC) are noted here;1 sample had MIC=12 µg/mL; 1 sample had MIC=16 µg/mL.
b2 samples had MIC=3 µg/mL.
c2 samples had MIC=0.125 µg/mL.
d1 sample had MIC=1.5 µg/mL; 1 sample had MIC=0.5 µg/mL.
e2 samples had MIC=0.02 µg/mL; 1 sample had MIC=0.016 µg/mL; 1 sample had MIC=0.008 µg/mL.
f1 sample had MIC=48 µg/mL.
g3 samples had MIC=6 µg/mL.